nodes	percent_of_prediction	percent_of_DWPC	metapath
Floxuridine—TYMS—prostate cancer	0.358	1	CbGaD
Floxuridine—TYMP—Capecitabine—prostate cancer	0.299	0.653	CbGbCtD
Floxuridine—TYMS—Capecitabine—prostate cancer	0.159	0.347	CbGbCtD
Floxuridine—TYMP—prostate gland—prostate cancer	0.00246	0.174	CbGeAlD
Floxuridine—TYMS—prostate gland—prostate cancer	0.00211	0.149	CbGeAlD
Floxuridine—TYMP—seminal vesicle—prostate cancer	0.00208	0.147	CbGeAlD
Floxuridine—TYMP—urethra—prostate cancer	0.00165	0.117	CbGeAlD
Floxuridine—TYMP—bone marrow—prostate cancer	0.00127	0.0897	CbGeAlD
Floxuridine—TYMS—bone marrow—prostate cancer	0.00109	0.077	CbGeAlD
Floxuridine—TYMS—Docetaxel—Cabazitaxel—prostate cancer	0.00109	0.349	CbGdCrCtD
Floxuridine—TYMP—testis—prostate cancer	0.00109	0.0767	CbGeAlD
Floxuridine—TYMS—testis—prostate cancer	0.000931	0.0658	CbGeAlD
Floxuridine—TYMP—lymph node—prostate cancer	0.000787	0.0556	CbGeAlD
Floxuridine—Decitabine—DNMT1—prostate cancer	0.000765	0.289	CrCbGaD
Floxuridine—TYMS—Paclitaxel—Cabazitaxel—prostate cancer	0.000752	0.241	CbGdCrCtD
Floxuridine—Zidovudine—TERT—prostate cancer	0.000731	0.276	CrCbGaD
Floxuridine—TYMS—lymph node—prostate cancer	0.000675	0.0477	CbGeAlD
Floxuridine—Trifluridine—TYMS—prostate cancer	0.000496	0.187	CrCbGaD
Floxuridine—TYMS—Paclitaxel—Docetaxel—prostate cancer	0.000312	0.1	CbGdCrCtD
Floxuridine—Zidovudine—CYP2A6—prostate cancer	0.000214	0.0809	CrCbGaD
Floxuridine—TYMS—Podofilox—Etoposide—prostate cancer	0.0002	0.0642	CbGdCrCtD
Floxuridine—TYMS—Levorphanol—Estrone—prostate cancer	0.000199	0.0636	CbGdCrCtD
Floxuridine—Cladribine—SLC22A1—prostate cancer	0.000193	0.073	CrCbGaD
Floxuridine—Zidovudine—CYP2C19—prostate cancer	0.000151	0.0569	CrCbGaD
Floxuridine—TYMS—Levorphanol—Estradiol—prostate cancer	0.00015	0.0482	CbGdCrCtD
Floxuridine—Abdominal pain—Goserelin—prostate cancer	0.000109	0.00102	CcSEcCtD
Floxuridine—Infection—Estradiol—prostate cancer	0.000109	0.00101	CcSEcCtD
Floxuridine—Abdominal pain—Conjugated Estrogens—prostate cancer	0.000108	0.00101	CcSEcCtD
Floxuridine—Body temperature increased—Conjugated Estrogens—prostate cancer	0.000108	0.00101	CcSEcCtD
Floxuridine—Stomatitis—Docetaxel—prostate cancer	0.000108	0.00101	CcSEcCtD
Floxuridine—Nervous system disorder—Estradiol—prostate cancer	0.000107	0.001	CcSEcCtD
Floxuridine—Vomiting—Ethinyl Estradiol—prostate cancer	0.000107	0.000995	CcSEcCtD
Floxuridine—Rash—Ethinyl Estradiol—prostate cancer	0.000106	0.000987	CcSEcCtD
Floxuridine—Dermatitis—Ethinyl Estradiol—prostate cancer	0.000106	0.000986	CcSEcCtD
Floxuridine—Alopecia—Etoposide—prostate cancer	0.000105	0.000984	CcSEcCtD
Floxuridine—Discomfort—Mitoxantrone—prostate cancer	0.000105	0.000981	CcSEcCtD
Floxuridine—Headache—Ethinyl Estradiol—prostate cancer	0.000105	0.00098	CcSEcCtD
Floxuridine—Stomatitis—Capecitabine—prostate cancer	0.000104	0.000973	CcSEcCtD
Floxuridine—Epistaxis—Docetaxel—prostate cancer	0.000104	0.000973	CcSEcCtD
Floxuridine—Thrombophlebitis—Doxorubicin—prostate cancer	0.000103	0.000965	CcSEcCtD
Floxuridine—Agranulocytosis—Docetaxel—prostate cancer	0.000103	0.000962	CcSEcCtD
Floxuridine—Confusional state—Mitoxantrone—prostate cancer	0.000103	0.000959	CcSEcCtD
Floxuridine—Anaphylactic shock—Mitoxantrone—prostate cancer	0.000102	0.000951	CcSEcCtD
Floxuridine—Photosensitivity—Doxorubicin—prostate cancer	0.000102	0.000951	CcSEcCtD
Floxuridine—Hypersensitivity—Goserelin—prostate cancer	0.000102	0.000949	CcSEcCtD
Floxuridine—Infection—Mitoxantrone—prostate cancer	0.000101	0.000945	CcSEcCtD
Floxuridine—Epistaxis—Capecitabine—prostate cancer	0.000101	0.000942	CcSEcCtD
Floxuridine—Hypersensitivity—Conjugated Estrogens—prostate cancer	0.000101	0.00094	CcSEcCtD
Floxuridine—Muscle spasms—Etoposide—prostate cancer	9.98e-05	0.000932	CcSEcCtD
Floxuridine—Agranulocytosis—Capecitabine—prostate cancer	9.97e-05	0.000932	CcSEcCtD
Floxuridine—Thrombocytopenia—Mitoxantrone—prostate cancer	9.97e-05	0.000932	CcSEcCtD
Floxuridine—Haemoglobin—Docetaxel—prostate cancer	9.96e-05	0.00093	CcSEcCtD
Floxuridine—Nausea—Ethinyl Estradiol—prostate cancer	9.95e-05	0.00093	CcSEcCtD
Floxuridine—TYMS—Danazol—Ethinyl Estradiol—prostate cancer	9.94e-05	0.0318	CbGdCrCtD
Floxuridine—Haemorrhage—Docetaxel—prostate cancer	9.91e-05	0.000926	CcSEcCtD
Floxuridine—Asthenia—Goserelin—prostate cancer	9.89e-05	0.000924	CcSEcCtD
Floxuridine—Lethargy—Epirubicin—prostate cancer	9.86e-05	0.000921	CcSEcCtD
Floxuridine—Pharyngitis—Docetaxel—prostate cancer	9.83e-05	0.000919	CcSEcCtD
Floxuridine—Asthenia—Conjugated Estrogens—prostate cancer	9.8e-05	0.000915	CcSEcCtD
Floxuridine—Anorexia—Mitoxantrone—prostate cancer	9.71e-05	0.000907	CcSEcCtD
Floxuridine—Haemoglobin—Capecitabine—prostate cancer	9.64e-05	0.000901	CcSEcCtD
Floxuridine—Ill-defined disorder—Etoposide—prostate cancer	9.63e-05	0.0009	CcSEcCtD
Floxuridine—Haemorrhage—Capecitabine—prostate cancer	9.59e-05	0.000896	CcSEcCtD
Floxuridine—Anaemia—Etoposide—prostate cancer	9.59e-05	0.000896	CcSEcCtD
Floxuridine—Zidovudine—CYP3A4—prostate cancer	9.58e-05	0.0362	CrCbGaD
Floxuridine—Pharyngitis—Capecitabine—prostate cancer	9.52e-05	0.00089	CcSEcCtD
Floxuridine—Decreased appetite—Estradiol—prostate cancer	9.5e-05	0.000888	CcSEcCtD
Floxuridine—Diarrhoea—Goserelin—prostate cancer	9.43e-05	0.000881	CcSEcCtD
Floxuridine—Malaise—Etoposide—prostate cancer	9.36e-05	0.000874	CcSEcCtD
Floxuridine—Diarrhoea—Conjugated Estrogens—prostate cancer	9.34e-05	0.000873	CcSEcCtD
Floxuridine—Leukopenia—Etoposide—prostate cancer	9.29e-05	0.000868	CcSEcCtD
Floxuridine—Lethargy—Doxorubicin—prostate cancer	9.12e-05	0.000852	CcSEcCtD
Floxuridine—Feeling abnormal—Estradiol—prostate cancer	9.01e-05	0.000841	CcSEcCtD
Floxuridine—Gastrointestinal pain—Estradiol—prostate cancer	8.94e-05	0.000835	CcSEcCtD
Floxuridine—Dry skin—Epirubicin—prostate cancer	8.86e-05	0.000827	CcSEcCtD
Floxuridine—Decreased appetite—Mitoxantrone—prostate cancer	8.85e-05	0.000827	CcSEcCtD
Floxuridine—Vomiting—Goserelin—prostate cancer	8.77e-05	0.000819	CcSEcCtD
Floxuridine—Alopecia—Docetaxel—prostate cancer	8.76e-05	0.000818	CcSEcCtD
Floxuridine—Discomfort—Etoposide—prostate cancer	8.73e-05	0.000816	CcSEcCtD
Floxuridine—Rash—Goserelin—prostate cancer	8.69e-05	0.000812	CcSEcCtD
Floxuridine—Dermatitis—Goserelin—prostate cancer	8.68e-05	0.000811	CcSEcCtD
Floxuridine—Vomiting—Conjugated Estrogens—prostate cancer	8.68e-05	0.000811	CcSEcCtD
Floxuridine—Abdominal pain—Estradiol—prostate cancer	8.64e-05	0.000807	CcSEcCtD
Floxuridine—Body temperature increased—Estradiol—prostate cancer	8.64e-05	0.000807	CcSEcCtD
Floxuridine—Headache—Goserelin—prostate cancer	8.64e-05	0.000807	CcSEcCtD
Floxuridine—Erythema—Docetaxel—prostate cancer	8.63e-05	0.000806	CcSEcCtD
Floxuridine—Rash—Conjugated Estrogens—prostate cancer	8.61e-05	0.000804	CcSEcCtD
Floxuridine—Dermatitis—Conjugated Estrogens—prostate cancer	8.6e-05	0.000804	CcSEcCtD
Floxuridine—Haemoglobin—Prednisone—prostate cancer	8.59e-05	0.000802	CcSEcCtD
Floxuridine—Headache—Conjugated Estrogens—prostate cancer	8.55e-05	0.000799	CcSEcCtD
Floxuridine—Gastritis—Epirubicin—prostate cancer	8.55e-05	0.000799	CcSEcCtD
Floxuridine—Haemorrhage—Prednisone—prostate cancer	8.55e-05	0.000798	CcSEcCtD
Floxuridine—Confusional state—Etoposide—prostate cancer	8.54e-05	0.000798	CcSEcCtD
Floxuridine—Alopecia—Capecitabine—prostate cancer	8.48e-05	0.000792	CcSEcCtD
Floxuridine—Anaphylactic shock—Etoposide—prostate cancer	8.47e-05	0.000791	CcSEcCtD
Floxuridine—Infection—Etoposide—prostate cancer	8.42e-05	0.000786	CcSEcCtD
Floxuridine—Feeling abnormal—Mitoxantrone—prostate cancer	8.39e-05	0.000784	CcSEcCtD
Floxuridine—Erythema—Capecitabine—prostate cancer	8.35e-05	0.00078	CcSEcCtD
Floxuridine—Gastrointestinal pain—Mitoxantrone—prostate cancer	8.33e-05	0.000778	CcSEcCtD
Floxuridine—Thrombocytopenia—Etoposide—prostate cancer	8.29e-05	0.000775	CcSEcCtD
Floxuridine—Muscle spasms—Docetaxel—prostate cancer	8.29e-05	0.000775	CcSEcCtD
Floxuridine—Dry skin—Doxorubicin—prostate cancer	8.19e-05	0.000765	CcSEcCtD
Floxuridine—Nausea—Goserelin—prostate cancer	8.19e-05	0.000765	CcSEcCtD
Floxuridine—Angina pectoris—Epirubicin—prostate cancer	8.13e-05	0.00076	CcSEcCtD
Floxuridine—Nausea—Conjugated Estrogens—prostate cancer	8.11e-05	0.000758	CcSEcCtD
Floxuridine—Anorexia—Etoposide—prostate cancer	8.07e-05	0.000754	CcSEcCtD
Floxuridine—Hypersensitivity—Estradiol—prostate cancer	8.05e-05	0.000752	CcSEcCtD
Floxuridine—Abdominal pain—Mitoxantrone—prostate cancer	8.05e-05	0.000752	CcSEcCtD
Floxuridine—Body temperature increased—Mitoxantrone—prostate cancer	8.05e-05	0.000752	CcSEcCtD
Floxuridine—Muscle spasms—Capecitabine—prostate cancer	8.03e-05	0.00075	CcSEcCtD
Floxuridine—Anaemia—Docetaxel—prostate cancer	7.97e-05	0.000745	CcSEcCtD
Floxuridine—Pancytopenia—Epirubicin—prostate cancer	7.93e-05	0.000741	CcSEcCtD
Floxuridine—Gastritis—Doxorubicin—prostate cancer	7.91e-05	0.000739	CcSEcCtD
Floxuridine—Asthenia—Estradiol—prostate cancer	7.84e-05	0.000733	CcSEcCtD
Floxuridine—Ill-defined disorder—Capecitabine—prostate cancer	7.75e-05	0.000724	CcSEcCtD
Floxuridine—Leukopenia—Docetaxel—prostate cancer	7.72e-05	0.000721	CcSEcCtD
Floxuridine—Anaemia—Capecitabine—prostate cancer	7.72e-05	0.000721	CcSEcCtD
Floxuridine—TYMS—Integrated Pancreatic Cancer Pathway—FASLG—prostate cancer	7.71e-05	0.00133	CbGpPWpGaD
Floxuridine—TYMS—Retinoblastoma (RB) in Cancer—CDKN1A—prostate cancer	7.67e-05	0.00132	CbGpPWpGaD
Floxuridine—Photosensitivity reaction—Epirubicin—prostate cancer	7.62e-05	0.000712	CcSEcCtD
Floxuridine—TYMP—Metabolism—LDHB—prostate cancer	7.58e-05	0.00131	CbGpPWpGaD
Floxuridine—Alopecia—Prednisone—prostate cancer	7.55e-05	0.000705	CcSEcCtD
Floxuridine—Malaise—Capecitabine—prostate cancer	7.53e-05	0.000704	CcSEcCtD
Floxuridine—Angina pectoris—Doxorubicin—prostate cancer	7.53e-05	0.000703	CcSEcCtD
Floxuridine—TYMS—Cell Cycle, Mitotic—HIST1H2BG—prostate cancer	7.51e-05	0.0013	CbGpPWpGaD
Floxuridine—Hypersensitivity—Mitoxantrone—prostate cancer	7.5e-05	0.000701	CcSEcCtD
Floxuridine—Diarrhoea—Estradiol—prostate cancer	7.48e-05	0.000699	CcSEcCtD
Floxuridine—Leukopenia—Capecitabine—prostate cancer	7.48e-05	0.000698	CcSEcCtD
Floxuridine—Erythema—Prednisone—prostate cancer	7.44e-05	0.000695	CcSEcCtD
Floxuridine—TYMP—Metabolism—CYP3A5—prostate cancer	7.44e-05	0.00128	CbGpPWpGaD
Floxuridine—Decreased appetite—Etoposide—prostate cancer	7.36e-05	0.000688	CcSEcCtD
Floxuridine—Pancytopenia—Doxorubicin—prostate cancer	7.34e-05	0.000685	CcSEcCtD
Floxuridine—TYMS—E2F transcription factor network—MYC—prostate cancer	7.32e-05	0.00126	CbGpPWpGaD
Floxuridine—Asthenia—Mitoxantrone—prostate cancer	7.31e-05	0.000683	CcSEcCtD
Floxuridine—Stomatitis—Epirubicin—prostate cancer	7.26e-05	0.000678	CcSEcCtD
Floxuridine—TYMS—Cell Cycle, Mitotic—HIST1H4H—prostate cancer	7.25e-05	0.00125	CbGpPWpGaD
Floxuridine—TYMP—Metabolism—TCN2—prostate cancer	7.18e-05	0.00124	CbGpPWpGaD
Floxuridine—TYMP—Metabolism—UCP3—prostate cancer	7.18e-05	0.00124	CbGpPWpGaD
Floxuridine—TYMP—Metabolism—PDHA1—prostate cancer	7.18e-05	0.00124	CbGpPWpGaD
Floxuridine—TYMP—Metabolism—GSTA3—prostate cancer	7.18e-05	0.00124	CbGpPWpGaD
Floxuridine—TYMS—Levonorgestrel—Ethinyl Estradiol—prostate cancer	7.13e-05	0.0228	CbGdCrCtD
Floxuridine—Confusional state—Docetaxel—prostate cancer	7.1e-05	0.000663	CcSEcCtD
Floxuridine—Photosensitivity reaction—Doxorubicin—prostate cancer	7.05e-05	0.000659	CcSEcCtD
Floxuridine—Anaphylactic shock—Docetaxel—prostate cancer	7.04e-05	0.000658	CcSEcCtD
Floxuridine—Discomfort—Capecitabine—prostate cancer	7.02e-05	0.000656	CcSEcCtD
Floxuridine—Epistaxis—Epirubicin—prostate cancer	7.02e-05	0.000656	CcSEcCtD
Floxuridine—Infection—Docetaxel—prostate cancer	6.99e-05	0.000653	CcSEcCtD
Floxuridine—Feeling abnormal—Etoposide—prostate cancer	6.98e-05	0.000652	CcSEcCtD
Floxuridine—Diarrhoea—Mitoxantrone—prostate cancer	6.97e-05	0.000651	CcSEcCtD
Floxuridine—Vomiting—Estradiol—prostate cancer	6.95e-05	0.000649	CcSEcCtD
Floxuridine—Agranulocytosis—Epirubicin—prostate cancer	6.95e-05	0.000649	CcSEcCtD
Floxuridine—TYMS—G1/S Transition—CDKN1B—prostate cancer	6.94e-05	0.0012	CbGpPWpGaD
Floxuridine—Gastrointestinal pain—Etoposide—prostate cancer	6.93e-05	0.000647	CcSEcCtD
Floxuridine—TYMS—Circadian rythm related genes—PPARA—prostate cancer	6.91e-05	0.00119	CbGpPWpGaD
Floxuridine—Nervous system disorder—Docetaxel—prostate cancer	6.9e-05	0.000645	CcSEcCtD
Floxuridine—Ill-defined disorder—Prednisone—prostate cancer	6.9e-05	0.000645	CcSEcCtD
Floxuridine—Thrombocytopenia—Docetaxel—prostate cancer	6.89e-05	0.000644	CcSEcCtD
Floxuridine—Rash—Estradiol—prostate cancer	6.89e-05	0.000644	CcSEcCtD
Floxuridine—Dermatitis—Estradiol—prostate cancer	6.88e-05	0.000643	CcSEcCtD
Floxuridine—TYMS—Metabolism—ADI1—prostate cancer	6.88e-05	0.00119	CbGpPWpGaD
Floxuridine—TYMS—Metabolism—PSAT1—prostate cancer	6.88e-05	0.00119	CbGpPWpGaD
Floxuridine—TYMS—Metabolism—CSAD—prostate cancer	6.88e-05	0.00119	CbGpPWpGaD
Floxuridine—TYMS—Metabolism—TST—prostate cancer	6.88e-05	0.00119	CbGpPWpGaD
Floxuridine—TYMS—Metabolism—GRHL1—prostate cancer	6.88e-05	0.00119	CbGpPWpGaD
Floxuridine—TYMS—Metabolism—CBR1—prostate cancer	6.88e-05	0.00119	CbGpPWpGaD
Floxuridine—Anaemia—Prednisone—prostate cancer	6.88e-05	0.000642	CcSEcCtD
Floxuridine—Confusional state—Capecitabine—prostate cancer	6.87e-05	0.000642	CcSEcCtD
Floxuridine—TYMP—Metabolism—HSD3B1—prostate cancer	6.85e-05	0.00118	CbGpPWpGaD
Floxuridine—TYMP—Metabolism—SLC22A3—prostate cancer	6.85e-05	0.00118	CbGpPWpGaD
Floxuridine—Headache—Estradiol—prostate cancer	6.85e-05	0.00064	CcSEcCtD
Floxuridine—TYMS—Cell Cycle, Mitotic—MAD1L1—prostate cancer	6.82e-05	0.00118	CbGpPWpGaD
Floxuridine—Infection—Capecitabine—prostate cancer	6.77e-05	0.000633	CcSEcCtD
Floxuridine—Haemoglobin—Epirubicin—prostate cancer	6.72e-05	0.000628	CcSEcCtD
Floxuridine—Stomatitis—Doxorubicin—prostate cancer	6.71e-05	0.000627	CcSEcCtD
Floxuridine—TYMS—Cell Cycle—HIST1H2BG—prostate cancer	6.71e-05	0.00116	CbGpPWpGaD
Floxuridine—Anorexia—Docetaxel—prostate cancer	6.71e-05	0.000627	CcSEcCtD
Floxuridine—Malaise—Prednisone—prostate cancer	6.71e-05	0.000627	CcSEcCtD
Floxuridine—Abdominal pain—Etoposide—prostate cancer	6.7e-05	0.000626	CcSEcCtD
Floxuridine—Body temperature increased—Etoposide—prostate cancer	6.7e-05	0.000626	CcSEcCtD
Floxuridine—Nervous system disorder—Capecitabine—prostate cancer	6.68e-05	0.000624	CcSEcCtD
Floxuridine—Haemorrhage—Epirubicin—prostate cancer	6.68e-05	0.000624	CcSEcCtD
Floxuridine—Thrombocytopenia—Capecitabine—prostate cancer	6.67e-05	0.000623	CcSEcCtD
Floxuridine—Pharyngitis—Epirubicin—prostate cancer	6.63e-05	0.00062	CcSEcCtD
Floxuridine—TYMS—Integrated Pancreatic Cancer Pathway—ATM—prostate cancer	6.57e-05	0.00113	CbGpPWpGaD
Floxuridine—TYMP—Metabolism—GSTA4—prostate cancer	6.57e-05	0.00113	CbGpPWpGaD
Floxuridine—TYMP—Metabolism—TBXAS1—prostate cancer	6.57e-05	0.00113	CbGpPWpGaD
Floxuridine—TYMS—Circadian rythm related genes—LEP—prostate cancer	6.55e-05	0.00113	CbGpPWpGaD
Floxuridine—TYMS—Integrated Pancreatic Cancer Pathway—ESR1—prostate cancer	6.52e-05	0.00113	CbGpPWpGaD
Floxuridine—Epistaxis—Doxorubicin—prostate cancer	6.5e-05	0.000607	CcSEcCtD
Floxuridine—Anorexia—Capecitabine—prostate cancer	6.5e-05	0.000607	CcSEcCtD
Floxuridine—Nausea—Estradiol—prostate cancer	6.49e-05	0.000607	CcSEcCtD
Floxuridine—TYMS—Cell Cycle—HIST1H4H—prostate cancer	6.48e-05	0.00112	CbGpPWpGaD
Floxuridine—Vomiting—Mitoxantrone—prostate cancer	6.47e-05	0.000605	CcSEcCtD
Floxuridine—Agranulocytosis—Doxorubicin—prostate cancer	6.43e-05	0.000601	CcSEcCtD
Floxuridine—Rash—Mitoxantrone—prostate cancer	6.42e-05	0.0006	CcSEcCtD
Floxuridine—Dermatitis—Mitoxantrone—prostate cancer	6.41e-05	0.000599	CcSEcCtD
Floxuridine—TYMS—G1/S Transition—CDKN1A—prostate cancer	6.4e-05	0.00111	CbGpPWpGaD
Floxuridine—TYMP—Metabolism—GSTA2—prostate cancer	6.4e-05	0.00111	CbGpPWpGaD
Floxuridine—TYMS—Metabolism—GRHPR—prostate cancer	6.4e-05	0.0011	CbGpPWpGaD
Floxuridine—TYMS—Metabolism—UGT2B15—prostate cancer	6.4e-05	0.0011	CbGpPWpGaD
Floxuridine—TYMS—Metabolism—UGT2B17—prostate cancer	6.4e-05	0.0011	CbGpPWpGaD
Floxuridine—TYMS—Metabolism—CKMT2—prostate cancer	6.4e-05	0.0011	CbGpPWpGaD
Floxuridine—Headache—Mitoxantrone—prostate cancer	6.38e-05	0.000596	CcSEcCtD
Floxuridine—TYMS—Integrated Pancreatic Cancer Pathway—BAD—prostate cancer	6.36e-05	0.0011	CbGpPWpGaD
Floxuridine—TYMS—Retinoblastoma (RB) in Cancer—MYC—prostate cancer	6.36e-05	0.0011	CbGpPWpGaD
Floxuridine—TYMP—Metabolism—SULT1A1—prostate cancer	6.32e-05	0.00109	CbGpPWpGaD
Floxuridine—TYMP—Metabolism—ABCG5—prostate cancer	6.32e-05	0.00109	CbGpPWpGaD
Floxuridine—Discomfort—Prednisone—prostate cancer	6.26e-05	0.000585	CcSEcCtD
Floxuridine—Hypersensitivity—Etoposide—prostate cancer	6.24e-05	0.000583	CcSEcCtD
Floxuridine—Haemoglobin—Doxorubicin—prostate cancer	6.22e-05	0.000581	CcSEcCtD
Floxuridine—Haemorrhage—Doxorubicin—prostate cancer	6.18e-05	0.000578	CcSEcCtD
Floxuridine—TYMP—Metabolism—GSTA1—prostate cancer	6.18e-05	0.00107	CbGpPWpGaD
Floxuridine—TYMS—Integrated Pancreatic Cancer Pathway—APC—prostate cancer	6.16e-05	0.00106	CbGpPWpGaD
Floxuridine—Pharyngitis—Doxorubicin—prostate cancer	6.14e-05	0.000573	CcSEcCtD
Floxuridine—Decreased appetite—Docetaxel—prostate cancer	6.12e-05	0.000572	CcSEcCtD
Floxuridine—TYMP—Metabolism—GSTO1—prostate cancer	6.11e-05	0.00105	CbGpPWpGaD
Floxuridine—TYMP—Metabolism—HSD3B2—prostate cancer	6.11e-05	0.00105	CbGpPWpGaD
Floxuridine—TYMP—Metabolism—NAT2—prostate cancer	6.11e-05	0.00105	CbGpPWpGaD
Floxuridine—TYMS—Cell Cycle—MAD1L1—prostate cancer	6.09e-05	0.00105	CbGpPWpGaD
Floxuridine—TYMS—Integrated Pancreatic Cancer Pathway—EGF—prostate cancer	6.09e-05	0.00105	CbGpPWpGaD
Floxuridine—Asthenia—Etoposide—prostate cancer	6.08e-05	0.000568	CcSEcCtD
Floxuridine—Anaphylactic shock—Prednisone—prostate cancer	6.07e-05	0.000567	CcSEcCtD
Floxuridine—Nausea—Mitoxantrone—prostate cancer	6.05e-05	0.000565	CcSEcCtD
Floxuridine—Infection—Prednisone—prostate cancer	6.03e-05	0.000563	CcSEcCtD
Floxuridine—TYMS—Metabolism—MBTPS1—prostate cancer	6.02e-05	0.00104	CbGpPWpGaD
Floxuridine—TYMS—Metabolism—SULT2B1—prostate cancer	6.02e-05	0.00104	CbGpPWpGaD
Floxuridine—TYMS—Metabolism—NAGLU—prostate cancer	6.02e-05	0.00104	CbGpPWpGaD
Floxuridine—TYMS—Metabolism—RFK—prostate cancer	6.02e-05	0.00104	CbGpPWpGaD
Floxuridine—TYMS—Metabolism—AOX1—prostate cancer	6.02e-05	0.00104	CbGpPWpGaD
Floxuridine—TYMS—Metabolism—PGAM2—prostate cancer	6.02e-05	0.00104	CbGpPWpGaD
Floxuridine—TYMS—Metabolism—GSTM3—prostate cancer	6.02e-05	0.00104	CbGpPWpGaD
Floxuridine—Nervous system disorder—Prednisone—prostate cancer	5.95e-05	0.000556	CcSEcCtD
Floxuridine—Decreased appetite—Capecitabine—prostate cancer	5.92e-05	0.000554	CcSEcCtD
Floxuridine—TYMS—Cell Cycle, Mitotic—TOP2A—prostate cancer	5.91e-05	0.00102	CbGpPWpGaD
Floxuridine—Alopecia—Epirubicin—prostate cancer	5.91e-05	0.000552	CcSEcCtD
Floxuridine—TYMP—Metabolism—LRP2—prostate cancer	5.86e-05	0.00101	CbGpPWpGaD
Floxuridine—TYMP—Metabolism—CYP2C18—prostate cancer	5.86e-05	0.00101	CbGpPWpGaD
Floxuridine—TYMP—Metabolism—PLCB2—prostate cancer	5.86e-05	0.00101	CbGpPWpGaD
Floxuridine—TYMS—Mitotic G1-G1/S phases—CDKN1B—prostate cancer	5.85e-05	0.00101	CbGpPWpGaD
Floxuridine—Erythema—Epirubicin—prostate cancer	5.82e-05	0.000544	CcSEcCtD
Floxuridine—Feeling abnormal—Docetaxel—prostate cancer	5.8e-05	0.000542	CcSEcCtD
Floxuridine—Diarrhoea—Etoposide—prostate cancer	5.8e-05	0.000541	CcSEcCtD
Floxuridine—Anorexia—Prednisone—prostate cancer	5.79e-05	0.000541	CcSEcCtD
Floxuridine—Gastrointestinal pain—Docetaxel—prostate cancer	5.76e-05	0.000538	CcSEcCtD
Floxuridine—TYMP—Metabolism—P4HB—prostate cancer	5.74e-05	0.000991	CbGpPWpGaD
Floxuridine—TYMS—Integrated Pancreatic Cancer Pathway—CREBBP—prostate cancer	5.71e-05	0.000986	CbGpPWpGaD
Floxuridine—TYMS—Metabolism—AMACR—prostate cancer	5.7e-05	0.000984	CbGpPWpGaD
Floxuridine—TYMS—Metabolism—CYP3A43—prostate cancer	5.7e-05	0.000984	CbGpPWpGaD
Floxuridine—TYMS—Metabolism—NAT1—prostate cancer	5.7e-05	0.000984	CbGpPWpGaD
Floxuridine—TYMS—Metabolism—SRD5A2—prostate cancer	5.7e-05	0.000984	CbGpPWpGaD
Floxuridine—TYMS—Metabolism—DEGS1—prostate cancer	5.7e-05	0.000984	CbGpPWpGaD
Floxuridine—TYMS—Circadian rythm related genes—GSK3B—prostate cancer	5.68e-05	0.00098	CbGpPWpGaD
Floxuridine—TYMS—Integrated Pancreatic Cancer Pathway—IGF1—prostate cancer	5.64e-05	0.000974	CbGpPWpGaD
Floxuridine—TYMS—Cell Cycle, Mitotic—AURKA—prostate cancer	5.64e-05	0.000973	CbGpPWpGaD
Floxuridine—Feeling abnormal—Capecitabine—prostate cancer	5.62e-05	0.000525	CcSEcCtD
Floxuridine—TYMS—Cell Cycle—NBN—prostate cancer	5.61e-05	0.000968	CbGpPWpGaD
Floxuridine—Muscle spasms—Epirubicin—prostate cancer	5.59e-05	0.000523	CcSEcCtD
Floxuridine—TYMP—Metabolism—SLC22A1—prostate cancer	5.59e-05	0.000964	CbGpPWpGaD
Floxuridine—TYMS—Mitotic G1-G1/S phases—CCND1—prostate cancer	5.58e-05	0.000963	CbGpPWpGaD
Floxuridine—TYMS—Cell Cycle—MLH1—prostate cancer	5.57e-05	0.000962	CbGpPWpGaD
Floxuridine—Gastrointestinal pain—Capecitabine—prostate cancer	5.57e-05	0.000521	CcSEcCtD
Floxuridine—Body temperature increased—Docetaxel—prostate cancer	5.56e-05	0.00052	CcSEcCtD
Floxuridine—Abdominal pain—Docetaxel—prostate cancer	5.56e-05	0.00052	CcSEcCtD
Floxuridine—Alopecia—Doxorubicin—prostate cancer	5.46e-05	0.000511	CcSEcCtD
Floxuridine—TYMS—Integrated Pancreatic Cancer Pathway—MAP2K1—prostate cancer	5.45e-05	0.000941	CbGpPWpGaD
Floxuridine—TYMP—Metabolism—SULT2A1—prostate cancer	5.44e-05	0.00094	CbGpPWpGaD
Floxuridine—TYMS—Metabolism—HSD17B1—prostate cancer	5.44e-05	0.000939	CbGpPWpGaD
Floxuridine—Ill-defined disorder—Epirubicin—prostate cancer	5.4e-05	0.000504	CcSEcCtD
Floxuridine—TYMS—Mitotic G1-G1/S phases—CDKN1A—prostate cancer	5.4e-05	0.000932	CbGpPWpGaD
Floxuridine—Body temperature increased—Capecitabine—prostate cancer	5.39e-05	0.000503	CcSEcCtD
Floxuridine—Abdominal pain—Capecitabine—prostate cancer	5.39e-05	0.000503	CcSEcCtD
Floxuridine—Vomiting—Etoposide—prostate cancer	5.39e-05	0.000503	CcSEcCtD
Floxuridine—Erythema—Doxorubicin—prostate cancer	5.38e-05	0.000503	CcSEcCtD
Floxuridine—Anaemia—Epirubicin—prostate cancer	5.38e-05	0.000502	CcSEcCtD
Floxuridine—TYMP—Metabolism—MED12—prostate cancer	5.36e-05	0.000924	CbGpPWpGaD
Floxuridine—Rash—Etoposide—prostate cancer	5.34e-05	0.000499	CcSEcCtD
Floxuridine—Dermatitis—Etoposide—prostate cancer	5.34e-05	0.000499	CcSEcCtD
Floxuridine—TYMP—Metabolism—GNG5—prostate cancer	5.31e-05	0.000917	CbGpPWpGaD
Floxuridine—TYMS—G1/S Transition—MYC—prostate cancer	5.31e-05	0.000917	CbGpPWpGaD
Floxuridine—Headache—Etoposide—prostate cancer	5.31e-05	0.000496	CcSEcCtD
Floxuridine—TYMS—Cell Cycle—TOP2A—prostate cancer	5.28e-05	0.000912	CbGpPWpGaD
Floxuridine—Decreased appetite—Prednisone—prostate cancer	5.28e-05	0.000493	CcSEcCtD
Floxuridine—Malaise—Epirubicin—prostate cancer	5.25e-05	0.00049	CcSEcCtD
Floxuridine—TYMS—Retinoblastoma (RB) in Cancer—TP53—prostate cancer	5.22e-05	0.000902	CbGpPWpGaD
Floxuridine—Leukopenia—Epirubicin—prostate cancer	5.21e-05	0.000487	CcSEcCtD
Floxuridine—Hypersensitivity—Docetaxel—prostate cancer	5.19e-05	0.000485	CcSEcCtD
Floxuridine—TYMS—Integrated Pancreatic Cancer Pathway—FGF2—prostate cancer	5.19e-05	0.000895	CbGpPWpGaD
Floxuridine—Muscle spasms—Doxorubicin—prostate cancer	5.18e-05	0.000484	CcSEcCtD
Floxuridine—TYMS—Circadian rythm related genes—SERPINE1—prostate cancer	5.14e-05	0.000888	CbGpPWpGaD
Floxuridine—TYMP—Metabolism—NCOA3—prostate cancer	5.12e-05	0.000884	CbGpPWpGaD
Floxuridine—Asthenia—Docetaxel—prostate cancer	5.05e-05	0.000472	CcSEcCtD
Floxuridine—TYMS—Cell Cycle—AURKA—prostate cancer	5.04e-05	0.00087	CbGpPWpGaD
Floxuridine—Nausea—Etoposide—prostate cancer	5.03e-05	0.00047	CcSEcCtD
Floxuridine—Hypersensitivity—Capecitabine—prostate cancer	5.02e-05	0.000469	CcSEcCtD
Floxuridine—Feeling abnormal—Prednisone—prostate cancer	5e-05	0.000467	CcSEcCtD
Floxuridine—Ill-defined disorder—Doxorubicin—prostate cancer	4.99e-05	0.000467	CcSEcCtD
Floxuridine—Anaemia—Doxorubicin—prostate cancer	4.98e-05	0.000465	CcSEcCtD
Floxuridine—Gastrointestinal pain—Prednisone—prostate cancer	4.96e-05	0.000464	CcSEcCtD
Floxuridine—TYMS—Integrated Pancreatic Cancer Pathway—BCL2—prostate cancer	4.92e-05	0.00085	CbGpPWpGaD
Floxuridine—TYMS—Cell Cycle, Mitotic—APEX1—prostate cancer	4.9e-05	0.000845	CbGpPWpGaD
Floxuridine—Discomfort—Epirubicin—prostate cancer	4.89e-05	0.000457	CcSEcCtD
Floxuridine—Asthenia—Capecitabine—prostate cancer	4.89e-05	0.000457	CcSEcCtD
Floxuridine—TYMP—Metabolism—HPGDS—prostate cancer	4.88e-05	0.000843	CbGpPWpGaD
Floxuridine—Malaise—Doxorubicin—prostate cancer	4.85e-05	0.000454	CcSEcCtD
Floxuridine—TYMS—Integrated Pancreatic Cancer Pathway—MDM2—prostate cancer	4.85e-05	0.000838	CbGpPWpGaD
Floxuridine—TYMP—Metabolism—CYP2C19—prostate cancer	4.85e-05	0.000838	CbGpPWpGaD
Floxuridine—TYMS—Metabolism—B4GALT4—prostate cancer	4.85e-05	0.000837	CbGpPWpGaD
Floxuridine—TYMS—Metabolism—HPGD—prostate cancer	4.85e-05	0.000837	CbGpPWpGaD
Floxuridine—Leukopenia—Doxorubicin—prostate cancer	4.82e-05	0.00045	CcSEcCtD
Floxuridine—Diarrhoea—Docetaxel—prostate cancer	4.82e-05	0.00045	CcSEcCtD
Floxuridine—Abdominal pain—Prednisone—prostate cancer	4.8e-05	0.000448	CcSEcCtD
Floxuridine—Body temperature increased—Prednisone—prostate cancer	4.8e-05	0.000448	CcSEcCtD
Floxuridine—Confusional state—Epirubicin—prostate cancer	4.79e-05	0.000447	CcSEcCtD
Floxuridine—TYMS—Integrated Pancreatic Cancer Pathway—ERBB2—prostate cancer	4.78e-05	0.000826	CbGpPWpGaD
Floxuridine—Anaphylactic shock—Epirubicin—prostate cancer	4.75e-05	0.000444	CcSEcCtD
Floxuridine—TYMP—Metabolism—GSTT1—prostate cancer	4.74e-05	0.000817	CbGpPWpGaD
Floxuridine—TYMP—Metabolism—ACHE—prostate cancer	4.74e-05	0.000817	CbGpPWpGaD
Floxuridine—TYMS—Cell Cycle, Mitotic—CCND2—prostate cancer	4.72e-05	0.000816	CbGpPWpGaD
Floxuridine—Infection—Epirubicin—prostate cancer	4.72e-05	0.000441	CcSEcCtD
Floxuridine—TYMP—Metabolism—CYP2A6—prostate cancer	4.68e-05	0.000808	CbGpPWpGaD
Floxuridine—TYMS—Integrated Pancreatic Cancer Pathway—PTGS2—prostate cancer	4.68e-05	0.000808	CbGpPWpGaD
Floxuridine—Diarrhoea—Capecitabine—prostate cancer	4.66e-05	0.000436	CcSEcCtD
Floxuridine—Nervous system disorder—Epirubicin—prostate cancer	4.66e-05	0.000435	CcSEcCtD
Floxuridine—Thrombocytopenia—Epirubicin—prostate cancer	4.65e-05	0.000434	CcSEcCtD
Floxuridine—TYMS—Clobetasol propionate—Prednisone—prostate cancer	4.62e-05	0.0148	CbGdCrCtD
Floxuridine—TYMS—Metabolism—TNFRSF21—prostate cancer	4.56e-05	0.000787	CbGpPWpGaD
Floxuridine—TYMS—Flunisolide—Prednisone—prostate cancer	4.56e-05	0.0146	CbGdCrCtD
Floxuridine—TYMP—Metabolism—AKR1C3—prostate cancer	4.55e-05	0.000786	CbGpPWpGaD
Floxuridine—TYMP—Metabolism—PRKACB—prostate cancer	4.53e-05	0.000782	CbGpPWpGaD
Floxuridine—Discomfort—Doxorubicin—prostate cancer	4.53e-05	0.000423	CcSEcCtD
Floxuridine—Anorexia—Epirubicin—prostate cancer	4.53e-05	0.000423	CcSEcCtD
Floxuridine—TYMS—Triamcinolone—Prednisone—prostate cancer	4.51e-05	0.0144	CbGdCrCtD
Floxuridine—TYMS—Cell Cycle—CHEK2—prostate cancer	4.51e-05	0.000778	CbGpPWpGaD
Floxuridine—TYMP—Metabolism—CYP17A1—prostate cancer	4.48e-05	0.000774	CbGpPWpGaD
Floxuridine—Vomiting—Docetaxel—prostate cancer	4.48e-05	0.000418	CcSEcCtD
Floxuridine—TYMS—Mitotic G1-G1/S phases—MYC—prostate cancer	4.48e-05	0.000772	CbGpPWpGaD
Floxuridine—Hypersensitivity—Prednisone—prostate cancer	4.47e-05	0.000418	CcSEcCtD
Floxuridine—Rash—Docetaxel—prostate cancer	4.44e-05	0.000415	CcSEcCtD
Floxuridine—TYMS—Metabolism—CYP7B1—prostate cancer	4.43e-05	0.000765	CbGpPWpGaD
Floxuridine—TYMS—Metabolism—MTAP—prostate cancer	4.43e-05	0.000765	CbGpPWpGaD
Floxuridine—Dermatitis—Docetaxel—prostate cancer	4.43e-05	0.000414	CcSEcCtD
Floxuridine—TYMS—Integrated Pancreatic Cancer Pathway—CDKN1B—prostate cancer	4.43e-05	0.000765	CbGpPWpGaD
Floxuridine—Confusional state—Doxorubicin—prostate cancer	4.43e-05	0.000414	CcSEcCtD
Floxuridine—Headache—Docetaxel—prostate cancer	4.41e-05	0.000412	CcSEcCtD
Floxuridine—Anaphylactic shock—Doxorubicin—prostate cancer	4.39e-05	0.00041	CcSEcCtD
Floxuridine—TYMS—Cell Cycle—APEX1—prostate cancer	4.38e-05	0.000756	CbGpPWpGaD
Floxuridine—Infection—Doxorubicin—prostate cancer	4.36e-05	0.000408	CcSEcCtD
Floxuridine—Asthenia—Prednisone—prostate cancer	4.36e-05	0.000407	CcSEcCtD
Floxuridine—TYMS—Integrated Pancreatic Cancer Pathway—CASP3—prostate cancer	4.34e-05	0.00075	CbGpPWpGaD
Floxuridine—Vomiting—Capecitabine—prostate cancer	4.33e-05	0.000405	CcSEcCtD
Floxuridine—TYMS—Metabolism—SULT1E1—prostate cancer	4.32e-05	0.000746	CbGpPWpGaD
Floxuridine—TYMS—Metabolism—SRD5A1—prostate cancer	4.32e-05	0.000746	CbGpPWpGaD
Floxuridine—Nervous system disorder—Doxorubicin—prostate cancer	4.31e-05	0.000403	CcSEcCtD
Floxuridine—Thrombocytopenia—Doxorubicin—prostate cancer	4.3e-05	0.000402	CcSEcCtD
Floxuridine—Rash—Capecitabine—prostate cancer	4.3e-05	0.000401	CcSEcCtD
Floxuridine—Dermatitis—Capecitabine—prostate cancer	4.29e-05	0.000401	CcSEcCtD
Floxuridine—TYMP—Metabolism—NCOA2—prostate cancer	4.27e-05	0.000737	CbGpPWpGaD
Floxuridine—Headache—Capecitabine—prostate cancer	4.27e-05	0.000399	CcSEcCtD
Floxuridine—TYMS—Integrated Pancreatic Cancer Pathway—CCND1—prostate cancer	4.23e-05	0.00073	CbGpPWpGaD
Floxuridine—TYMS—Cell Cycle—CCND2—prostate cancer	4.22e-05	0.000729	CbGpPWpGaD
Floxuridine—TYMS—Cell Cycle—BRCA1—prostate cancer	4.22e-05	0.000729	CbGpPWpGaD
Floxuridine—Anorexia—Doxorubicin—prostate cancer	4.19e-05	0.000391	CcSEcCtD
Floxuridine—TYMS—Integrated Pancreatic Cancer Pathway—CTNNB1—prostate cancer	4.19e-05	0.000723	CbGpPWpGaD
Floxuridine—Nausea—Docetaxel—prostate cancer	4.18e-05	0.000391	CcSEcCtD
Floxuridine—TYMS—Diflorasone—Prednisone—prostate cancer	4.16e-05	0.0133	CbGdCrCtD
Floxuridine—Diarrhoea—Prednisone—prostate cancer	4.15e-05	0.000388	CcSEcCtD
Floxuridine—Decreased appetite—Epirubicin—prostate cancer	4.13e-05	0.000386	CcSEcCtD
Floxuridine—TYMS—Metabolism—HSD17B3—prostate cancer	4.12e-05	0.000712	CbGpPWpGaD
Floxuridine—TYMS—Metabolism—ACSL4—prostate cancer	4.12e-05	0.000712	CbGpPWpGaD
Floxuridine—TYMS—Integrated Pancreatic Cancer Pathway—CDKN1A—prostate cancer	4.09e-05	0.000706	CbGpPWpGaD
Floxuridine—TYMS—Integrated Pancreatic Cancer Pathway—PTEN—prostate cancer	4.08e-05	0.000704	CbGpPWpGaD
Floxuridine—TYMP—Metabolism—SLC5A5—prostate cancer	4.08e-05	0.000703	CbGpPWpGaD
Floxuridine—Nausea—Capecitabine—prostate cancer	4.05e-05	0.000378	CcSEcCtD
Floxuridine—TYMP—Metabolism—CYP2E1—prostate cancer	3.98e-05	0.000687	CbGpPWpGaD
Floxuridine—TYMS—Metabolism—UMPS—prostate cancer	3.95e-05	0.000682	CbGpPWpGaD
Floxuridine—TYMS—Metabolism—PHGDH—prostate cancer	3.95e-05	0.000682	CbGpPWpGaD
Floxuridine—TYMS—Metabolism—ARG2—prostate cancer	3.95e-05	0.000682	CbGpPWpGaD
Floxuridine—TYMP—Metabolism—NQO1—prostate cancer	3.94e-05	0.000679	CbGpPWpGaD
Floxuridine—TYMS—Circadian rythm related genes—PTEN—prostate cancer	3.92e-05	0.000676	CbGpPWpGaD
Floxuridine—Feeling abnormal—Epirubicin—prostate cancer	3.91e-05	0.000366	CcSEcCtD
Floxuridine—TYMS—Integrated Pancreatic Cancer Pathway—EP300—prostate cancer	3.89e-05	0.000672	CbGpPWpGaD
Floxuridine—Gastrointestinal pain—Epirubicin—prostate cancer	3.88e-05	0.000363	CcSEcCtD
Floxuridine—TYMP—Metabolism—TH—prostate cancer	3.88e-05	0.00067	CbGpPWpGaD
Floxuridine—TYMS—Metabolism—LDHB—prostate cancer	3.88e-05	0.000669	CbGpPWpGaD
Floxuridine—Vomiting—Prednisone—prostate cancer	3.86e-05	0.000361	CcSEcCtD
Floxuridine—TYMP—Metabolism—CYP3A4—prostate cancer	3.84e-05	0.000663	CbGpPWpGaD
Floxuridine—Rash—Prednisone—prostate cancer	3.83e-05	0.000358	CcSEcCtD
Floxuridine—Dermatitis—Prednisone—prostate cancer	3.82e-05	0.000357	CcSEcCtD
Floxuridine—TYMS—Cell Cycle—BRCA2—prostate cancer	3.82e-05	0.000659	CbGpPWpGaD
Floxuridine—Decreased appetite—Doxorubicin—prostate cancer	3.82e-05	0.000357	CcSEcCtD
Floxuridine—TYMS—Metabolism—CYP3A5—prostate cancer	3.8e-05	0.000657	CbGpPWpGaD
Floxuridine—Headache—Prednisone—prostate cancer	3.8e-05	0.000355	CcSEcCtD
Floxuridine—TYMS—Integrated Pancreatic Cancer Pathway—SRC—prostate cancer	3.78e-05	0.000653	CbGpPWpGaD
Floxuridine—TYMP—Metabolism—CYP1B1—prostate cancer	3.77e-05	0.000651	CbGpPWpGaD
Floxuridine—Body temperature increased—Epirubicin—prostate cancer	3.75e-05	0.000351	CcSEcCtD
Floxuridine—Abdominal pain—Epirubicin—prostate cancer	3.75e-05	0.000351	CcSEcCtD
Floxuridine—TYMS—Circadian rythm related genes—EP300—prostate cancer	3.74e-05	0.000645	CbGpPWpGaD
Floxuridine—TYMS—Integrated Pancreatic Cancer Pathway—VEGFA—prostate cancer	3.68e-05	0.000636	CbGpPWpGaD
Floxuridine—TYMS—Metabolism—PDHA1—prostate cancer	3.67e-05	0.000634	CbGpPWpGaD
Floxuridine—TYMS—Metabolism—TCN2—prostate cancer	3.67e-05	0.000634	CbGpPWpGaD
Floxuridine—TYMS—Metabolism—GSTA3—prostate cancer	3.67e-05	0.000634	CbGpPWpGaD
Floxuridine—TYMS—Metabolism—UCP3—prostate cancer	3.67e-05	0.000634	CbGpPWpGaD
Floxuridine—TYMP—Metabolism—GGT1—prostate cancer	3.65e-05	0.000631	CbGpPWpGaD
Floxuridine—TYMS—Budesonide—Prednisone—prostate cancer	3.64e-05	0.0117	CbGdCrCtD
Floxuridine—Feeling abnormal—Doxorubicin—prostate cancer	3.62e-05	0.000338	CcSEcCtD
Floxuridine—Nausea—Prednisone—prostate cancer	3.61e-05	0.000337	CcSEcCtD
Floxuridine—TYMP—Metabolism—NCOA1—prostate cancer	3.6e-05	0.000621	CbGpPWpGaD
Floxuridine—Gastrointestinal pain—Doxorubicin—prostate cancer	3.59e-05	0.000336	CcSEcCtD
Floxuridine—TYMP—Metabolism—CYP19A1—prostate cancer	3.55e-05	0.000612	CbGpPWpGaD
Floxuridine—TYMS—Metabolism—HSD3B1—prostate cancer	3.51e-05	0.000605	CbGpPWpGaD
Floxuridine—TYMS—Metabolism—SLC22A3—prostate cancer	3.51e-05	0.000605	CbGpPWpGaD
Floxuridine—Hypersensitivity—Epirubicin—prostate cancer	3.5e-05	0.000327	CcSEcCtD
Floxuridine—TYMS—Danazol—Prednisone—prostate cancer	3.49e-05	0.0112	CbGdCrCtD
Floxuridine—Body temperature increased—Doxorubicin—prostate cancer	3.47e-05	0.000324	CcSEcCtD
Floxuridine—Abdominal pain—Doxorubicin—prostate cancer	3.47e-05	0.000324	CcSEcCtD
Floxuridine—TYMP—Metabolism—RXRA—prostate cancer	3.42e-05	0.000591	CbGpPWpGaD
Floxuridine—Asthenia—Epirubicin—prostate cancer	3.41e-05	0.000318	CcSEcCtD
Floxuridine—TYMS—Integrated Pancreatic Cancer Pathway—MYC—prostate cancer	3.39e-05	0.000585	CbGpPWpGaD
Floxuridine—TYMS—Integrated Pancreatic Cancer Pathway—TGFB1—prostate cancer	3.38e-05	0.000584	CbGpPWpGaD
Floxuridine—TYMS—Metabolism—TBXAS1—prostate cancer	3.36e-05	0.00058	CbGpPWpGaD
Floxuridine—TYMS—Metabolism—GSTA4—prostate cancer	3.36e-05	0.00058	CbGpPWpGaD
Floxuridine—TYMS—Integrated Pancreatic Cancer Pathway—EGFR—prostate cancer	3.32e-05	0.000572	CbGpPWpGaD
Floxuridine—TYMP—Metabolism—COMT—prostate cancer	3.3e-05	0.000569	CbGpPWpGaD
Floxuridine—TYMP—Metabolism—GSTP1—prostate cancer	3.28e-05	0.000567	CbGpPWpGaD
Floxuridine—TYMS—Metabolism—GSTA2—prostate cancer	3.28e-05	0.000565	CbGpPWpGaD
Floxuridine—Diarrhoea—Epirubicin—prostate cancer	3.25e-05	0.000304	CcSEcCtD
Floxuridine—Hypersensitivity—Doxorubicin—prostate cancer	3.24e-05	0.000302	CcSEcCtD
Floxuridine—TYMS—Metabolism—SULT1A1—prostate cancer	3.24e-05	0.000558	CbGpPWpGaD
Floxuridine—TYMS—Metabolism—ABCG5—prostate cancer	3.24e-05	0.000558	CbGpPWpGaD
Floxuridine—TYMP—Metabolism—ITPR1—prostate cancer	3.23e-05	0.000558	CbGpPWpGaD
Floxuridine—TYMS—Cell Cycle—TERT—prostate cancer	3.17e-05	0.000546	CbGpPWpGaD
Floxuridine—TYMS—Metabolism—GSTA1—prostate cancer	3.16e-05	0.000545	CbGpPWpGaD
Floxuridine—Asthenia—Doxorubicin—prostate cancer	3.15e-05	0.000294	CcSEcCtD
Floxuridine—TYMS—Integrated Pancreatic Cancer Pathway—KRAS—prostate cancer	3.13e-05	0.000541	CbGpPWpGaD
Floxuridine—TYMS—Metabolism—GSTO1—prostate cancer	3.12e-05	0.000539	CbGpPWpGaD
Floxuridine—TYMS—Metabolism—NAT2—prostate cancer	3.12e-05	0.000539	CbGpPWpGaD
Floxuridine—TYMS—Metabolism—HSD3B2—prostate cancer	3.12e-05	0.000539	CbGpPWpGaD
Floxuridine—TYMP—Metabolism—TYMS—prostate cancer	3.05e-05	0.000527	CbGpPWpGaD
Floxuridine—Vomiting—Epirubicin—prostate cancer	3.02e-05	0.000282	CcSEcCtD
Floxuridine—TYMP—Metabolism—GSTM1—prostate cancer	3.02e-05	0.000521	CbGpPWpGaD
Floxuridine—Diarrhoea—Doxorubicin—prostate cancer	3.01e-05	0.000281	CcSEcCtD
Floxuridine—TYMS—Metabolism—CYP2C18—prostate cancer	3e-05	0.000517	CbGpPWpGaD
Floxuridine—TYMS—Metabolism—LRP2—prostate cancer	3e-05	0.000517	CbGpPWpGaD
Floxuridine—TYMS—Metabolism—PLCB2—prostate cancer	3e-05	0.000517	CbGpPWpGaD
Floxuridine—Rash—Epirubicin—prostate cancer	2.99e-05	0.00028	CcSEcCtD
Floxuridine—Dermatitis—Epirubicin—prostate cancer	2.99e-05	0.000279	CcSEcCtD
Floxuridine—Headache—Epirubicin—prostate cancer	2.97e-05	0.000278	CcSEcCtD
Floxuridine—TYMP—Metabolism—LPL—prostate cancer	2.96e-05	0.000511	CbGpPWpGaD
Floxuridine—TYMS—Metabolism—P4HB—prostate cancer	2.94e-05	0.000507	CbGpPWpGaD
Floxuridine—TYMS—Integrated Pancreatic Cancer Pathway—PIK3CA—prostate cancer	2.88e-05	0.000497	CbGpPWpGaD
Floxuridine—TYMP—Metabolism—CYP1A1—prostate cancer	2.86e-05	0.000494	CbGpPWpGaD
Floxuridine—TYMS—Metabolism—SLC22A1—prostate cancer	2.86e-05	0.000493	CbGpPWpGaD
Floxuridine—TYMS—Cell Cycle—ATM—prostate cancer	2.85e-05	0.000491	CbGpPWpGaD
Floxuridine—TYMP—Metabolism—ERCC2—prostate cancer	2.84e-05	0.00049	CbGpPWpGaD
Floxuridine—Nausea—Epirubicin—prostate cancer	2.82e-05	0.000263	CcSEcCtD
Floxuridine—Vomiting—Doxorubicin—prostate cancer	2.79e-05	0.000261	CcSEcCtD
Floxuridine—TYMS—Metabolism—SULT2A1—prostate cancer	2.78e-05	0.000481	CbGpPWpGaD
Floxuridine—TYMS—Integrated Pancreatic Cancer Pathway—TP53—prostate cancer	2.78e-05	0.000481	CbGpPWpGaD
Floxuridine—Rash—Doxorubicin—prostate cancer	2.77e-05	0.000259	CcSEcCtD
Floxuridine—Dermatitis—Doxorubicin—prostate cancer	2.77e-05	0.000259	CcSEcCtD
Floxuridine—Headache—Doxorubicin—prostate cancer	2.75e-05	0.000257	CcSEcCtD
Floxuridine—TYMS—Metabolism—MED12—prostate cancer	2.74e-05	0.000473	CbGpPWpGaD
Floxuridine—TYMS—Metabolism—GNG5—prostate cancer	2.72e-05	0.000469	CbGpPWpGaD
Floxuridine—TYMS—Circadian rythm related genes—TP53—prostate cancer	2.67e-05	0.000461	CbGpPWpGaD
Floxuridine—TYMP—Metabolism—MTHFR—prostate cancer	2.67e-05	0.00046	CbGpPWpGaD
Floxuridine—TYMS—Metabolism—NCOA3—prostate cancer	2.62e-05	0.000452	CbGpPWpGaD
Floxuridine—TYMP—Metabolism—PPARA—prostate cancer	2.62e-05	0.000451	CbGpPWpGaD
Floxuridine—Nausea—Doxorubicin—prostate cancer	2.61e-05	0.000244	CcSEcCtD
Floxuridine—TYMS—Metabolism—HPGDS—prostate cancer	2.5e-05	0.000431	CbGpPWpGaD
Floxuridine—TYMS—Metabolism—CYP2C19—prostate cancer	2.48e-05	0.000428	CbGpPWpGaD
Floxuridine—TYMP—Metabolism—CAV1—prostate cancer	2.46e-05	0.000424	CbGpPWpGaD
Floxuridine—TYMS—Circadian rythm related genes—IL6—prostate cancer	2.45e-05	0.000422	CbGpPWpGaD
Floxuridine—TYMS—Metabolism—GSTT1—prostate cancer	2.42e-05	0.000418	CbGpPWpGaD
Floxuridine—TYMS—Metabolism—ACHE—prostate cancer	2.42e-05	0.000418	CbGpPWpGaD
Floxuridine—TYMS—Metabolism—CYP2A6—prostate cancer	2.39e-05	0.000413	CbGpPWpGaD
Floxuridine—TYMS—Integrated Pancreatic Cancer Pathway—AKT1—prostate cancer	2.35e-05	0.000406	CbGpPWpGaD
Floxuridine—TYMS—Metabolism—AKR1C3—prostate cancer	2.33e-05	0.000402	CbGpPWpGaD
Floxuridine—TYMS—Metabolism—PRKACB—prostate cancer	2.32e-05	0.0004	CbGpPWpGaD
Floxuridine—TYMS—Metabolism—CYP17A1—prostate cancer	2.29e-05	0.000396	CbGpPWpGaD
Floxuridine—TYMP—Metabolism—PIK3CG—prostate cancer	2.24e-05	0.000387	CbGpPWpGaD
Floxuridine—TYMS—Metabolism—NCOA2—prostate cancer	2.19e-05	0.000377	CbGpPWpGaD
Floxuridine—TYMS—Cell Cycle, Mitotic—CDKN1B—prostate cancer	2.14e-05	0.00037	CbGpPWpGaD
Floxuridine—TYMP—Metabolism—INS—prostate cancer	2.12e-05	0.000366	CbGpPWpGaD
Floxuridine—TYMS—Cell Cycle—MDM2—prostate cancer	2.1e-05	0.000363	CbGpPWpGaD
Floxuridine—TYMS—Metabolism—SLC5A5—prostate cancer	2.08e-05	0.00036	CbGpPWpGaD
Floxuridine—TYMP—Metabolism—CREBBP—prostate cancer	2.08e-05	0.000358	CbGpPWpGaD
Floxuridine—TYMS—Cell Cycle, Mitotic—CCND1—prostate cancer	2.05e-05	0.000353	CbGpPWpGaD
Floxuridine—TYMS—Metabolism—CYP2E1—prostate cancer	2.04e-05	0.000351	CbGpPWpGaD
Floxuridine—TYMS—Metabolism—NQO1—prostate cancer	2.01e-05	0.000348	CbGpPWpGaD
Floxuridine—TYMS—Metabolism—TH—prostate cancer	1.98e-05	0.000343	CbGpPWpGaD
Floxuridine—TYMS—Cell Cycle, Mitotic—CDKN1A—prostate cancer	1.98e-05	0.000342	CbGpPWpGaD
Floxuridine—TYMP—Metabolism—PIK3CD—prostate cancer	1.97e-05	0.00034	CbGpPWpGaD
Floxuridine—TYMS—Metabolism—CYP3A4—prostate cancer	1.96e-05	0.000339	CbGpPWpGaD
Floxuridine—TYMS—Metabolism—CYP1B1—prostate cancer	1.93e-05	0.000333	CbGpPWpGaD
Floxuridine—TYMS—Cell Cycle—CDKN1B—prostate cancer	1.92e-05	0.000331	CbGpPWpGaD
Floxuridine—TYMS—Cell Cycle, Mitotic—EP300—prostate cancer	1.88e-05	0.000325	CbGpPWpGaD
Floxuridine—TYMS—Metabolism—GGT1—prostate cancer	1.87e-05	0.000323	CbGpPWpGaD
Floxuridine—TYMP—Metabolism—NOS3—prostate cancer	1.86e-05	0.000321	CbGpPWpGaD
Floxuridine—TYMS—Metabolism—NCOA1—prostate cancer	1.84e-05	0.000318	CbGpPWpGaD
Floxuridine—TYMS—Cell Cycle—CCND1—prostate cancer	1.83e-05	0.000316	CbGpPWpGaD
Floxuridine—TYMS—Metabolism—CYP19A1—prostate cancer	1.81e-05	0.000313	CbGpPWpGaD
Floxuridine—TYMS—Cell Cycle—CDKN1A—prostate cancer	1.77e-05	0.000306	CbGpPWpGaD
Floxuridine—TYMS—Metabolism—RXRA—prostate cancer	1.75e-05	0.000302	CbGpPWpGaD
Floxuridine—TYMP—Metabolism—PIK3CB—prostate cancer	1.72e-05	0.000296	CbGpPWpGaD
Floxuridine—TYMP—Metabolism—PTGS2—prostate cancer	1.7e-05	0.000294	CbGpPWpGaD
Floxuridine—TYMS—Metabolism—COMT—prostate cancer	1.69e-05	0.000291	CbGpPWpGaD
Floxuridine—TYMS—Cell Cycle—EP300—prostate cancer	1.68e-05	0.000291	CbGpPWpGaD
Floxuridine—TYMS—Metabolism—GSTP1—prostate cancer	1.68e-05	0.00029	CbGpPWpGaD
Floxuridine—TYMS—Metabolism—ITPR1—prostate cancer	1.65e-05	0.000285	CbGpPWpGaD
Floxuridine—TYMS—Cell Cycle, Mitotic—MYC—prostate cancer	1.64e-05	0.000283	CbGpPWpGaD
Floxuridine—TYMS—Metabolism—GSTM1—prostate cancer	1.54e-05	0.000266	CbGpPWpGaD
Floxuridine—TYMS—Metabolism—LPL—prostate cancer	1.51e-05	0.000261	CbGpPWpGaD
Floxuridine—TYMP—Metabolism—PTEN—prostate cancer	1.48e-05	0.000256	CbGpPWpGaD
Floxuridine—TYMS—Cell Cycle—MYC—prostate cancer	1.47e-05	0.000253	CbGpPWpGaD
Floxuridine—TYMS—Metabolism—CYP1A1—prostate cancer	1.46e-05	0.000253	CbGpPWpGaD
Floxuridine—TYMS—Metabolism—ERCC2—prostate cancer	1.45e-05	0.00025	CbGpPWpGaD
Floxuridine—TYMP—Metabolism—EP300—prostate cancer	1.41e-05	0.000244	CbGpPWpGaD
Floxuridine—TYMS—Metabolism—MTHFR—prostate cancer	1.36e-05	0.000235	CbGpPWpGaD
Floxuridine—TYMS—Metabolism—PPARA—prostate cancer	1.34e-05	0.000231	CbGpPWpGaD
Floxuridine—TYMS—Metabolism—CAV1—prostate cancer	1.26e-05	0.000217	CbGpPWpGaD
Floxuridine—TYMS—Cell Cycle—TP53—prostate cancer	1.21e-05	0.000208	CbGpPWpGaD
Floxuridine—TYMS—Metabolism—PIK3CG—prostate cancer	1.15e-05	0.000198	CbGpPWpGaD
Floxuridine—TYMS—Metabolism—INS—prostate cancer	1.08e-05	0.000187	CbGpPWpGaD
Floxuridine—TYMS—Metabolism—CREBBP—prostate cancer	1.06e-05	0.000183	CbGpPWpGaD
Floxuridine—TYMP—Metabolism—PIK3CA—prostate cancer	1.05e-05	0.000181	CbGpPWpGaD
Floxuridine—TYMS—Metabolism—PIK3CD—prostate cancer	1.01e-05	0.000174	CbGpPWpGaD
Floxuridine—TYMS—Metabolism—NOS3—prostate cancer	9.51e-06	0.000164	CbGpPWpGaD
Floxuridine—TYMS—Metabolism—PIK3CB—prostate cancer	8.78e-06	0.000152	CbGpPWpGaD
Floxuridine—TYMS—Metabolism—PTGS2—prostate cancer	8.7e-06	0.00015	CbGpPWpGaD
Floxuridine—TYMP—Metabolism—AKT1—prostate cancer	8.55e-06	0.000148	CbGpPWpGaD
Floxuridine—TYMS—Metabolism—PTEN—prostate cancer	7.59e-06	0.000131	CbGpPWpGaD
Floxuridine—TYMS—Metabolism—EP300—prostate cancer	7.24e-06	0.000125	CbGpPWpGaD
Floxuridine—TYMS—Metabolism—PIK3CA—prostate cancer	5.35e-06	9.24e-05	CbGpPWpGaD
Floxuridine—TYMS—Metabolism—AKT1—prostate cancer	4.37e-06	7.55e-05	CbGpPWpGaD
